Literature DB >> 11580230

Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice.

F Rosignoli1, N B Goren, C Pérez Leirós.   

Abstract

The non-obese diabetic (NOD) mouse model of autoimmune sialadenitis offers the possibility of studying the L-arginine/nitric oxide signaling pathway in salivary glands in basal and neurotransmitter-stimulated conditions and, thus, of analyzing the neural control of the secretory process in the target organ. The purpose of this study was to explore putative alterations in the activity and expression of nitric oxide synthase (NOS) in submandibular glands of NOD mice in relation to parotid glands and unrelated tissues. Here we report that NOD mice with incipient signs of secretory dysfunction presented a marked decrease in basal and vasoactive intestinal peptide (VIP)-stimulated NOS activity and a differential expression of NOS I in submandibular glands compared to control BALB/c mice. Similar alterations in NOS I were found in parotid glands but not in brain or spleen of NOD mice. No differences between NOD and controls appeared in NOS II and NOS III expression in any of the tissues studied. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580230     DOI: 10.1006/clim.2001.5097

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis.

Authors:  F Rosignoli; V Roca; R Meiss; J Leceta; R P Gomariz; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Salivary exosomes as a new therapy to ameliorate diabetes mellitus and combat xerostomia and submandibular salivary glands dysfunction in diabetic rats.

Authors:  Zeinab A Salem; Amany Hany Mohamed Kamel; Nermeen AbuBakr
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

3.  Compensatory renal growth protects mice against Shiga toxin 2-induced toxicity.

Authors:  Gabriela Verónica Camerano; Oscar David Bustuoabad; Roberto Pablo Meiss; Sonia Alejandra Gómez; Gabriela Cristina Fernández; Martín Amadeo Isturiz; Marina Sandra Palermo; Graciela Isabel Dran
Journal:  Pediatr Nephrol       Date:  2006-05-16       Impact factor: 3.714

4.  Inhibition of calcium-calmodulin kinase restores nitric oxide production and signaling in submandibular glands of a mouse model of salivary dysfunction.

Authors:  Florencia Rosignoli; Valeria Roca; Roberto Meiss; Nicolás Pregi; Claudia Pérez Leirós
Journal:  Br J Pharmacol       Date:  2004-11-08       Impact factor: 8.739

5.  Effects of Diabetes on Salivary Gland Protein Expression of Tetrahydrobiopterin and Nitric Oxide Synthesis and Function.

Authors:  Cassandra R Stewart; Nneka Obi; Elodie C Epane; Alexander A Akbari; Leslie Halpern; Janet H Southerland; Pandu R Gangula
Journal:  J Periodontol       Date:  2016-01-16       Impact factor: 6.993

6.  Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.

Authors:  V Hauk; L Fraccaroli; E Grasso; A Eimon; R Ramhorst; O Hubscher; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

7.  Human dental pulp stem cells attenuate streptozotocin-induced parotid gland injury in rats.

Authors:  Rasha H Al-Serwi; Ahmed Othman Fathy Othman El-Kersh; Gehan El-Akabawy
Journal:  Stem Cell Res Ther       Date:  2021-11-14       Impact factor: 6.832

8.  Impaired vascular responses to parasympathetic nerve stimulation and muscarinic receptor activation in the submandibular gland in nonobese diabetic mice.

Authors:  Ellen Berggreen; Krister Nyløkken; Nicolas Delaleu; Hamijeta Hajdaragic-Ibricevic; Malin V Jonsson
Journal:  Arthritis Res Ther       Date:  2009-02-06       Impact factor: 5.156

9.  Acute salivary gland hypofunction in the duct ligation model in the absence of inflammation.

Authors:  P N Correia; G H Carpenter; S M Osailan; K L Paterson; G B Proctor
Journal:  Oral Dis       Date:  2008-01-22       Impact factor: 3.511

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.